227 related articles for article (PubMed ID: 9428995)
1. Urinary excretion of endogenous ouabain-like substance in furosemide-treated neonates: its relation to renal excretory pattern and endocrine factors.
Sulyok E; Adamovits K; Worgall S; Rascher W
Biol Neonate; 1997; 72(6):352-62. PubMed ID: 9428995
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of endogenous ouabain-like substance is reduced in NaCl supplemented premature infants.
Worgall S; Rascher W; Gyódi G; Nyul Z; Baranyai Z; Sulyok E
Biol Neonate; 1997; 72(6):337-44. PubMed ID: 9428993
[TBL] [Abstract][Full Text] [Related]
3. Urinary aldosterone excretion and renal function in extremely-low-birth-weight infants following acute furosemide therapy.
Costa S; Gallini F; De Carolis MP; Latella C; Maggio L; Zecca C; Romagnoli C
Neonatology; 2009; 96(3):171-4. PubMed ID: 19332997
[TBL] [Abstract][Full Text] [Related]
4. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of water and electrolytes during open-sea saturation diving to 850 fsw.
Neuman TS; Goad RF; Hall D; Smith RM; Claybaugh JR; Hong SK
Undersea Biomed Res; 1979 Sep; 6(3):291-302. PubMed ID: 524529
[TBL] [Abstract][Full Text] [Related]
6. Renal electrolyte and water handling in normal pregnancy: possible role of endothelin-1.
Tamás P; Worgall S; Sulyok E; Rascher W
Eur J Obstet Gynecol Reprod Biol; 1994 Jun; 55(2):89-95. PubMed ID: 7958155
[TBL] [Abstract][Full Text] [Related]
7. Urinary ET-1, AVP and sodium in premature infants treated with indomethacin and ibuprofen for patent ductus arteriosus.
Zanardo V; Vedovato S; Lago P; Trevisanuto D; Favaro F; Faggian D; Plebani M
Pediatr Nephrol; 2005 Nov; 20(11):1552-6. PubMed ID: 16133044
[TBL] [Abstract][Full Text] [Related]
8. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the diuretic, natriuretic, and kaluretic effects of furosemide when administered at 07:00 h and at 19:00 h.
Hemal AK; Thind SK; Nath R; Sidhu HK; Sankaranarayanan A; Vaidyanathan S
Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):314-6. PubMed ID: 3410608
[TBL] [Abstract][Full Text] [Related]
10. Hormonal response to acute diuresis--a comparative study of furosemide and azosemide.
Ogawa K; Hatano T; Yamamoto M; Matsui N
Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):284-90. PubMed ID: 6378806
[TBL] [Abstract][Full Text] [Related]
11. Furosemide-induced alterations in the electrolyte status, the function of renin-angiotensin-aldosterone system, and the urinary excretion of prostaglandins in newborn infants.
Sulyok E; Varga F; Németh M; Tényi I; Csaba IF; Ertl T; Györy E
Pediatr Res; 1980 May; 14(5):765-8. PubMed ID: 6992087
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291
[TBL] [Abstract][Full Text] [Related]
13. Effects of sodium intake, furosemide, and infusion of atrial natriuretic peptide on the urinary and metabolic clearances of arginine vasopressin in normal subjects.
Moses AM; Jones C; Yucha CB
J Clin Endocrinol Metab; 1990 Jan; 70(1):222-9. PubMed ID: 2136743
[TBL] [Abstract][Full Text] [Related]
14. Renin-aldosterone axis and arginine-vasopressin responses to sodium depletion in camels.
Riad F; Ben Goumi M; Giry J; Davicco MJ; Safwate A; Barlet JP
Gen Comp Endocrinol; 1994 Aug; 95(2):240-7. PubMed ID: 7958753
[TBL] [Abstract][Full Text] [Related]
15. Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.
Ohnishi A; Orita Y; Okahara R; Fujihara H; Inoue T; Yamamura Y; Yabuuchi Y; Tanaka T
J Clin Invest; 1993 Dec; 92(6):2653-9. PubMed ID: 8254021
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic assessment of diuretic efficacy and braking in a furosemide continuous infusion model.
Adin D; Atkins C; Papich MG
J Vet Cardiol; 2018 Apr; 20(2):92-101. PubMed ID: 29483040
[TBL] [Abstract][Full Text] [Related]
17. Effect of single dose of diuretics on renal magnesium excretion in man, with special reference to their site of action.
Sotorník I; Schück O
Physiol Bohemoslov; 1976; 25(3):207-12. PubMed ID: 133359
[TBL] [Abstract][Full Text] [Related]
18. Regulation of renal water excretion in newborn full-term infants.
Aperia A; Herin P; Lundin S; Melin P; Zetterström R
Acta Paediatr Scand; 1984 Nov; 73(6):717-21. PubMed ID: 6524361
[TBL] [Abstract][Full Text] [Related]
19. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
20. Abnormal renal sodium excretion in the nephrotic syndrome after furosemide: relation to glomerular filtration rate.
Danielsen H; Pedersen EB; Madsen M; Jensen T
Acta Med Scand; 1985; 217(5):513-8. PubMed ID: 4025007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
